Table 6 The changes in CGI score in the atypical group and the anxiety group
Variables | Anxiety (n = 111) | Atypical (n = 63) | ||||||
|---|---|---|---|---|---|---|---|---|
Enrolment n (%) | 3Â months later n (%) | Z1 | Enrolment n (%) | 3Â months later n (%) | 6Â months later n (%) | Z2 | Z3 | |
Disease severity | Â | Â | 2.583** | Â | Â | Â | 0.674 | 2.435** |
 No assessment | 0 | 0 |  | 0 | 0 | 0 |  |  |
 Normal | 0 | 5 (4.5) |  | 0 | 0 | 4 (6.3) |  |  |
 Borderline | 0 | 35 (31.5) |  | 0 | 0 | 23 (36.5) |  |  |
 Mild | 10 (9.0) | 55 (49.5) |  | 9 (14.3) | 12 (19.0) | 27 (42.9) |  |  |
 Moderate | 36 (32.4) | 16 (14.5) |  | 22 (34.9) | 25 (39.7) | 9 (14.3) |  |  |
 Obvious | 45 (40.5) | 0 |  | 24 (38.1) | 19 (30.2) | 0 |  |  |
 Severe | 12 (10.8) | 0 |  | 7 (11.1) | 6 (9.5) | 0 |  |  |
 Most severe | 8 (7.3) | 0 |  | 1 (1.6) | 1 (1.6) | 0 |  |  |
Overall efficacy | Â | Â | 3.689*** | Â | Â | Â | Â | Â |
 No assessment | 111 | 0 |  | 63 | 0 | 0 | 0.968 | 2.874** |
 Obviously improved | 0 | 64 (57.7) |  | 0 | 0 | 41 (65.1) |  |  |
 Improved | 0 | 39 (35.1) |  | 0 | 0 | 16 (25.4) |  |  |
 Slightly improved | 0 | 8 (7.2) |  | 0 | 0 | 6 (9.5) |  |  |
 No change | 0 | 0 |  | 0 | 61 (96.8) | 0 |  |  |
 Slightly deteriorated | 0 | 0 |  | 0 | 2 (3.2) | 0 |  |  |
 Deteriorative | 0 | 0 |  | 0 | 0 | 0 |  |  |
 Obviously deteriorated | 0 | 0 |  | 0 | 0 | 0 |  |  |